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Summary
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Background—The HIV Infant Tracking System (HITSystem) is a web-based intervention
linking providers of early infant diagnosis, laboratory technicians, and mothers and infants to
improve outcomes for HIV-exposed infants. We aimed to evaluate the efficacy of the HITSystem
on key outcomes of early infant diagnosis.
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Methods—We did a cluster-randomised trial at six hospitals in Kenya, which were matched on
geographic region, resource level, and volume of patients (high, medium, and low). We randomly
allocated hospitals within a matched pair to either the HITSystem (intervention; n=3) or standard
of care (control; n=3). A random number generator was used to assign clusters. Investigators were
unaware of the randomisation process. Eligible participants were mothers aged 18 years or older
with an infant younger than 24 weeks presenting for their first early infant diagnosis appointment.
The primary outcome was complete early infant diagnosis retention, which was defined as receipt
of all indicated age-specific interventions until 18 months post partum (for HIV-negative infants)
or antiretroviral therapy initiation (for HIV-positive infants). Analysis was per protocol in all
randomised pairs judged eligible, excluding infant deaths and those who moved or were
transferred to another health facility. Modified intention-to-treat sensitivity analyses judged all
infant deaths and transfers as incomplete early infant diagnosis retention. Separate multivariable
logistic regression analyses were done with intervention group, hospital volume, and significant
covariates as fixed effects. This trial is registered with ClinicalTrials.gov, number NCT02072603;
the trial has been completed.

Author Manuscript

Findings—Between Feb 16, 2014, and Dec 31, 2015, 895 mother–infant pairs were enrolled. Of
these, 87 were judged ineligible for analysis, 26 infants died, and 92 pairs moved or were
transferred to another health facility. Thus, data from 690 mother–infant pairs were analysed, of
whom 392 were allocated to the HITSystem and 298 to standard of care. Mother–infant pairs were
followed up to Sept 30, 2017. Infants diagnosed as HIV-positive were followed up for a median of
2·1 months (IQR 1·6–4·8) and HIV-negative infants were followed up for a median of 17·0 months
(IQR 16·6–17·6). Infants enrolled in the HITSystem were significantly more likely to receive
complete early infant diagnosis services compared with those assigned standard of care (334 of
392 [85%] vs 180 of 298 [60%]; adjusted odds ratio [OR] 3·7, 95% CI 2·5–5·5; p<0·0001). No
intervention effect was recorded at high-volume hospitals, but strong effects were seen at mediumvolume and low-volume hospitals. Modified intention-to-treat analyses for complete early infant
diagnosis were also significant (334 of 474 [70%] vs 180 of 334 [54%]; adjusted OR 2·0, 95% CI
1·4–2·7; p<0·0001). No adverse events related to study participation were reported.
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Interpretation—The HITSystem intervention is effective and feasible to implement in lowresource settings. The HITSystem algorithms have been modified to include HIV testing at birth,
and an adapted HITSystem 2.0 version is supporting HIV-positive pregnant women to prevent
perinatal transmission and optimise maternal and infant outcomes.

Introduction

Author Manuscript
Author Manuscript

For HIV-exposed infants aged from 6 weeks up to 18 months, early infant diagnosis is a
critical and time-sensitive service to identify HIV-positive infants for rapid initiation of
lifesaving antiretroviral therapy (ART). In Kenya, the early infant diagnosis cascade of care
includes a series of age-specific interventions to clinically manage, test, and retest infants
until 18 months of age and initiate ART rapidly when indicated. These interventions include
collection of a dried bloodspot sample for HIV DNA PCR testing at 6 weeks of age, sample
shipment to and processing at a central laboratory, return of the paper-based PCR result back
to the health facility, notifying the mother of the infant’s PCR result, and either ART
initiation for HIV-positive infants or antibody retests at 9 months and 18 months for HIVnegative infants.1 In 2012, early infant diagnosis reached approximately 39% of HIVexposed infants in Kenya,2 with only 38% of HIV-positive infants and children identified
through these services initiating ART.3 Data from 2016 show improvements, with 53% of
HIV-exposed infants receiving early infant diagnosis and 65% of HIV-positive infants and
children identified initiating ART.4 Nevertheless, early infant diagnosis services and
outcomes still fall well short of evidence-based targets to optimise infant survival by testing
all HIV-exposed infants by 6 weeks of age and initiating ART for HIV-positive infants by 12
weeks of age.5 The quality and efficiency of early infant diagnosis services in Kenya and
other low-resource settings remain hampered by system and structural barriers, including
late presentation for care,6 long turnaround times for PCR results to be returned to the
hospital then communicated to mothers,7 suboptimum retention of infants up to 18 months
of age,7 and delayed ART initiation for HIV-positive infants.8

Author Manuscript

In 2011, Global Health Innovations—a non-governmental organisation based in the USA
and Kenya—developed the HIV Infant Tracking System (HITSystem) intervention in
partnership with the digital marketing firm OnTarget Interactive (Kansas City, MO, USA), to
address the limitations of early infant diagnosis services in low-resource settings. The
HITSystem uses available technology (internet and short message service [SMS] texting) to
improve communication and accountability between early infant diagnosis stakeholders
(providers, laboratories, and parents), to optimise outcomes for HIV-exposed infants. The
HITSystem aims to expedite PCR test results, facilitate rapid initiation of ART, and increase
retention. Infants are tracked until either they are ascertained conclusively to be HIVnegative at age 18 months and discharged from early infant diagnosis or they are established
to be HIV-positive and initiated on ART.9,10
At the time we had the idea for our study in 2012, the rate of mobile phone use in Kenya was
estimated at 75%,11 and evidence for mobile health (mHealth) interventions for HIV was
promising but scant. Findings of two Kenyan randomised controlled trials showed
significantly improved HIV treatment outcomes with weekly text messages to adult patients.
12,13 The first efforts to apply mHealth strategies to improve early infant diagnosis focused
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solely on reducing turnaround time for infant PCR results,14 and electronic product design
printers (typically referred to as SMS printers) providing one-way communication (from
laboratory to health facility) had been deployed in African countries.15,16 Nevertheless, no
data from randomised controlled trials assessing mHealth interventions had been published
on early infant diagnosis outcomes.
We designed a cluster-randomised trial to assess the efficacy of the HITSystem to improve
key measures of early infant diagnosis quality and efficiency in Kenya. The HITSystem
targets multiple clinical, laboratory, and participant engagement outcomes to assess
comprehensively complete early infant diagnosis—ie, completion of all eligible services
throughout the early infant diagnosis cascade of services. We also aimed to assess the
turnaround time of multiple time-sensitive early infant diagnosis services.

Author Manuscript

Methods
Study design and participants

Author Manuscript

We did a parallel group, cluster-randomised study at six government hospitals in Kenya. We
matched hospitals on geographic region, resource level, and volume of patients to produce
three matched pairs. Matched hospitals met the following criteria: government funded;
provided prevention of mother-to-child transmission (PMTCT), early infant diagnosis, and
ART services; had at least one dedicated early infant diagnosis provider; and maintained
medical files for HIV-exposed infants. Risk of contamination between intervention and
control hospitals was small owing to the geographic distance between sites and because a
login and password was required to access the HITSystem. Intervention sites were provided
with a wireless modem, so wired internet connectivity was not a requirement. The appendix
(p 1) provides additional details about study sites.
We judged mothers eligible to enrol in our trial if they met the following criteria: they were
HIV-positive; aged 18 years or older; had an HIV-exposed infant presenting for their first
early infant diagnosis appointment through the maternal and child health department; and
presented for early infant diagnosis care when their infant was younger than 24 weeks.
Mothers enrolled in early infant diagnosis services at intervention sites who did not meet our
eligbility criteria were still offered the HITSystem intervention, but their data were excluded
from analyses.

Author Manuscript

We established a data safety monitoring board (DSMB) at the beginning of the study, which
consisted of three people with expertise in epidemiology and paediatric HIV, to ensure safety
of participants and to undertake a prespecified interim analysis planned at the midpoint of
data collection. Study protocol and informed consent forms (available in English and
Swahili) were approved by ethics review committees at the Kenya Medical Research
Institute (KEMRI) and the University of Kansas Medical Center. The study protocol has
been published10 and is available online.
Randomisation and masking
All individuals enrolled in the trial at each hospital comprised a cluster for randomisation.
Hospitals within a matched pair were assigned to either control (standard of care) or
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intervention (HITSystem) using a random number generator. The study statistician was
unaware of the identity of study sites. Similarly, all research staff were unaware of the
randomisation process.
Procedures
At both intervention and control sites, eligible mothers were informed about the trial by
trained research or clinical staff; those choosing to participate provided written informed
consent before enrolment. Mothers completed a baseline survey at the time of early infant
diagnosis enrolment, which included information on demographics, HIV disclosure status,
and early infant diagnosis knowledge. The baseline survey was administered by trained
research staff (intervention sites) or trained clinical staff (control sites). Study staff entered
survey data into a protected Microsoft Excel 2016 (version 1708) spreadsheet, and we
merged these data with each infant’s clinical data for final analyses.

Author Manuscript
Author Manuscript

At intervention sites, we captured clinical data in the HITSystem and stored them securely
on Ubuntu LAMP (Linux, Apache, MySQL, and PHP) servers, which we backed up daily to
preserve the integrity of entered data. When an eligible mother–infant pair first presented for
early infant diagnosis care, we created a new infant record in the HITSystem and entered
data for the mother’s antenatal care, post-partum infant prophylaxis, and the infant’s date of
birth. We also added the mother’s mobile phone number to the HITSystem to enable
automated messages when her infant required follow-up services. The HITSystem identifies
receipt of text messages and absorbs all SMS costs. Messages do not relay sensitive
information that could compromise confidentiality but use the field-tested message in
Swahili, “Tafadhali mlete mtoto kwenye kliniki” (the English translation is “please bring
baby to the clinic”). If a mother did not have a mobile phone, we obtained physical tracing
information. At completion of each subsequent early infant diagnosis service, we accessed
the infant’s HITSystem record using a unique numeric identifier and updated the record. We
exported HITSystem data directly to an Excel spreadsheet. In response to calls for improved
reporting of implementation strategies for interventions,17 the appendix (p 2) specifies the
key actors, actions, timing, dose, and targeted behavioural or clinical outcome of each
intervention component.

Author Manuscript

At control sites, participants received services comprising the standard of care—ie, paperbased tracking of HIV-exposed infants with no enhanced or automated follow-up. Providers
recorded clinical data in the HIV-exposed infant register, which is the standard paper-based
register that clinicians use to record all early infant diagnosis services. A study staff member
populated an Excel spreadsheet with datapoints captured in the HIV-exposed infant register
to assess early infant diagnosis outcomes at control sites. Study coordinators visited control
sites once every 2 weeks and reviewed the HIV-exposed infant register for services received
by mother–infant pairs, and they updated the spreadsheet accordingly. We obtained all data
from control sites using a unique numeric identifier for each mother–infant pair.
At both intervention and control sites, study personnel did quarterly reviews of additional
documentation, including participants’ files, ART-specific records for HIV-positive infants,
and records from the hospital’s internal laboratory to fill in data missing or recorded
incorrectly in the HIV-exposed infant register or the HITSystem. Participants in both
Lancet HIV. Author manuscript; available in PMC 2019 December 01.

Finocchario-Kessler et al.

Page 6

Author Manuscript

intervention and control clusters were tracked from time of enrolment to: HIV-positive
diagnosis and ART initiation; completion of 18-month services (we followed up infants to
age 21 months to allow for complete reporting of 18-month services for infants who were
brought to hospital late for early infant diagnosis); or discharge from the HITSystem (infant
death or documented transfer to another health facility).
Outcomes

Author Manuscript

The primary outcome was complete early infant diagnosis retention, defined as completion
of all eligible services, which comprised: initiation of co-trimoxazole (sulfamethoxazole and
trimethoprim) for opportunistic infection prophylaxis; PCR testing; return of the PCR result
to the hospital; notifying the mother of the PCR result; initiation of ART (HIV-positive
infants only); and retesting at 9 months and 18 months (HIV-negative infants only). We
scored this binary measure of complete early infant diagnosis as 1 if all indicated services
were received or 0 if one or more service was missed. Consistent with the emerging standard
for retention analyses in PMTCT, early infant diagnosis, and paediatric ART,7,18,19 we
accounted for deaths and recorded clinic transfers and excluded these from analyses.

Author Manuscript

Secondary outcomes included turnaround time for key time-sensitive steps in the early infant
diagnosis cascade of care. We defined turnaround time for PCR test results as the number of
days between sample collection and receipt of the PCR result at the hospital. We calculated
turnaround time for notifying the mother of the PCR result as the number of days between
receipt of infant PCR results at the hospital and the mother being notified of the PCR results.
We measured the turnaround time for ART initiation among HIV-positive infants as the
number of days between the mother being notified of the PCR result and ART initiation. We
ascertained age at ART by the number of weeks between the infant’s date of birth and the
date the infant initiated ART. We established the age at repeated testing—targeted at 9
months and 18 months—by the number of months between the infant’s date of birth and the
date of each retest.
Additional secondary outcomes in the study protocol included the provider’s perceptions of
HITSystem usefulness and ease of use, the mothers’ experiences with the HITSystem, and
cost-effectiveness analyses. These outcomes will be reported separately.
Statistical analysis

Author Manuscript

We based sample size calculations on unadjusted odds ratios (ORs) obtained in our pilot
work, comparing historical control data with intervention data for early infant diagnosis
outcomes, ranging from PCR testing by 6 weeks of age (47·4% vs 68·2%; OR 2·4 [effect
size 0·42]) to retention at 9-month retesting (43·2% vs 94·1%; OR 21·0 [effect size 1·22]).9
We chose a fairly conservative effect size estimate within this range (0·44) to guarantee
adequate power to assess the primary outcome of complete early infant diagnosis at the
longer retention period of 18 months post partum. Using Murray’s methods to conduct
power for randomised trials,20 we accounted for the number of groups, participants in each
group, one-tailed test of significance, and intraclass correlation coefficient (ICC) ranging
between 0·01 and 0·05. Using an ICC estimate of 0·05, we calculated that a sample of 720
infants (360 each from intervention and control sites [120 per hospital]) was sufficient to
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detect with 80% power an effect size of 0·44. Because of multiple planned comparisons
along the early infant diagnosis cascade, we used a more conservative α of 0·01 to adjust for
possible inflated type I error. After data analyses were done, we became aware of an error in
the initial sample size calculation, resulting in a study design with half the number of
clusters necessary for detecting small effects. Ultimately, we recorded differences between
groups that were much larger than the conservative effect size estimates and variables used
to calculate power. Thus, despite being underpowered, significant differences between
intervention and control sites were noted.

Author Manuscript

To maintain consistency in the period being compared, each pair of matched hospitals
continued enrolment until the target at both sites was met. Thus, some sites enrolled more
than the targeted 120 participants. Among the matched high-volume sites, enrolment of
infants for early infant diagnosis was significantly greater at the intervention site. Slower
than expected enrolment among matched low-volume sites lengthened the enrolment period
for this cluster.

Author Manuscript
Author Manuscript

We analysed the primary outcome of complete early infant diagnosis retention per protocol,
excluding infant deaths and those who transferred to another health facility from both the
intervention and control clusters. We identified participants’ characteristics associated with
PMTCT and early infant diagnosis retention using χ2 tests and independent sample t tests to
ascertain significant baseline differences between groups. We compared the proportion of
infants receiving each intervention across the early infant diagnosis cascade of care, and we
treated the aggregated primary outcome of complete early infant diagnosis retention as a
response variable in a multivariable logistic regression model. Similarly, we analysed
turnaround times in separate Poisson regression models adjusted for overdispersion to
produce a robust model fit. For all regression models, we included the intervention as the
main effect, and site-level variables—eg, volume of patients—were included as fixed effects.
In the models, we controlled for theoretically supported individual-level covariates that have
been associated with the outcome in previous research and differed significantly between
intervention and control sites—ie, maternal age, level of education, and HIV disclosure
status. We present the primary outcome as the proportion of participants with complete early
infant diagnosis services, by group, with an adjusted OR, 95% CI, and p value. Because of
the small number of HIV-positive infants and skewed distribution of ART-related data, we
did non-parametric Mann-Whitney U tests to compare median values specific to HIVpositive infants (ART initiation turnaround time and age at ART initiation) between study
groups. We also calculated mean infant ages at the targeted 9-month and 18-month retesting
timepoints and compared these by group using an independent sample t test. In effectmodification analyses, we assessed whether the intervention effect differed across type of
hospital by including an interaction term between the intervention and hospital volume
(high, medium, and low). We report adjusted ORs (with 95% CIs) and p values for the
interaction test. Finally, we did a modified intention-to-treat sensitivity analysis, which
included all randomised infants with at least 18 months’ post-partum follow-up. This
intention-to-treat analysis counted all infant deaths and transfers or moves to a new health
facility as incomplete early infant diagnosis, thus establishing the most rigorous standard to
measure an intervention effect. We judged significance at an α of 0·05. We did all analyses
with SAS version 9.4.
Lancet HIV. Author manuscript; available in PMC 2019 December 01.
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The DSMB did one, prespecified, interim analysis in June, 2016, and ascertained that there
were significant findings indicating clinically meaningful advantages for participants
receiving the intervention. The DSMB recommended stopping enrolment and proceeding
with study analyses once all enrolled infants had been followed up for 21 months (18
months post partum plus an additional 3 months to capture any late testing), to ensure that
receipt of all services that make up the primary outcome of complete early infant diagnosis
could be recorded. This curtailment meant that the low-volume sites, which accrued
participants at a slower pace than high-volume sites, did not enrol their original target
samples. In July, 2016, Kenyan early infant diagnosis testing guidelines were changed
unexpectedly, removing 9-month HIV antibody testing and adding PCR tests at birth, 6
months, and 12 months.21 We monitored all study sites closely for evidence of adoption of
these new testing guidelines, with two study sites showing implemention in June, 2017. This
change in practice meant that infants born after Dec 31, 2015, at these two sites would not
have the same testing timepoints as the rest of the participants in the cluster, thus precluding
a consistent definition of the main outcome of complete early infant diagnosis. As such, we
excluded all infants enrolled after Dec 31, 2015, from the final analysis set. We analysed the
final dataset after Sept 30, 2017.

Author Manuscript

This trial is registered with ClinicalTrials.gov, number NCT02072603.

Results

Author Manuscript

Between Feb 12, 2014, and Dec 31, 2016, we screened 1019 mother–infant pairs for
inclusion in our trial, of whom 895 were enrolled and randomised. 87 pairs were judged
ineligible for analysis and were excluded (40 at intervention sites and 47 at control sites), of
whom five were mothers younger than 18 years, 20 were infants who had their first dried
bloodspot test at more than 24 weeks, and 62 were infants born after Dec 31, 2015. Another
26 infants died (17 at intervention sites and nine at control sites) and 92 pairs were
transferred or moved to another health facility (65 from intervention sites and 27 at control
sites), including three mothers from intervention sites who refused follow-up care for their
infants. Therefore, 690 mother–infant pairs were included in analyses, 392 at intervention
sites and 298 at control sites (figure 1). No significant differences between intervention and
control sites were noted in key participants’ characteristics (ie, maternal age, education level,
and HIV disclosure status) among mothers or infants deemed ineligible or pairs who were
transferred or moved to another health facility. Only 15 (1%) mothers declined to participate
in the trial, and no one withdrew from the study. Median infant age at enrolment was 6·4
weeks (IQR 6·1–7·3) and 344 (50%) of 690 infants were male (table 1).

Author Manuscript

392 (100%) participants at intervention sites were enrolled in the HITSystem. Infants
diagnosed as HIVpositive received the intervention for a median of 2·1 months (IQR 1·6–
4·8) between early infant diagnosis enrolment and ART initiation, and HIV-negative infants
received intervention follow-up for a median of 17·0 months (IQR 16·6–17·6) between early
infant diagnosis enrolment and the 18-month retest. Text messages were sent directly to 373
(95%) of 392 mothers; six women provided a phone number for their designated community
health-care worker to receive notifications, and 12 mothers did not provide phone numbers.
1495 text messages were sent in total, of which 1096 (73%) were confirmed received by the
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recipients’ phones; a median of 3·0 texts (range 1–10) were received per participant. No
disruptions were reported to daily access of the HITSystem during the study period;
however, no text messages were sent during a 1-week period in January, 2015, and an error
in programming resulted in missed provider alerts and automated text messages for 9-month
retesting for 57 infants who reached 9 months of age before November, 2014, when the issue
was identified and corrected. Complete early infant diagnosis among these 57 infants did not
differ significantly from the remainder of the infants at intervention sites (p=0·06).
Compared with control sites, mothers at intervention sites were older, had lower education,
and were less likely to have disclosed their HIV status to anyone (table 1). These variables
were all controlled for in subsequent analyses.

Author Manuscript
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The HITSystem intervention had a significant effect on receipt of complete early infant
diagnosis services compared with standard of care (figure 2). A higher proportion of infants
enrolled in the HITSystem received complete early infant diagnosis compared with controls
(334 [85%] of 392 vs 180 [60%] of 298; adjusted OR 3·7, 95% CI 2·5–5·5; p<0–0001).
Hospital volume, maternal age, education level, HIV disclosure status, and an interaction
effect between study arm and hospital volume were treated as fixed effects in this model.
Within this aggregate measure of complete early infant diagnosis services, 391 (100%) of
392 participants at intervention sites received prophylaxis for opportunistic infections (vs
267 [90%] of 298 at control sites), 392 (100%) of 392 had initial dried bloodspot sample
collection (vs 296 [99%] of 298), 392 (100%) of 392 had PCR results returned to hospital
(vs 289 [97%] of 298), 388 (99%) of 392 mothers were notified of the the PCR result (vs
266 [89%] of 298), 360 (97%) of 372 HIV-negative infants were retested at 9 months (vs
265 [91%] of 291), 315 (85%) of 372 HIV-negative infants were retested at 18 months (vs
201 [69%] of 290), and 21 (100%) of 21 HIV-positive infants at intervention sites initiated
ART (vs eight [73%] of 11 HIV-positive infants at control sites).
When analysed by volume of patients at each hospital, a significant interaction between
hospital volume and study group was noted. The effect of the HITSystem on complete early
infant diagnosis at high-volume hospitals in the intervention and control groups was not
significant; however, the odds of receiving complete early infant diagnosis services
increased significantly at medium-volume and low-volume hospitals implementing the
HITSystem (table 2). When analysed as a modified intention-to-treat approach, with all
infant deaths and transfers to other facilities regarded as not achieving complete early infant
diagnosis, the HITSystem intervention effect on complete early infant diagnosis retention
remained significant.

Author Manuscript

HIV-exposed infants enrolled in the HITSystem received more efficient early infant
diagnosis services compared with those receiving standard of care at control hospitals.
Results from the initial PCR test were returned faster for infants at intervention sites
compared with control sites (median 20·0 days [IQR 15·0–32·0] vs 38·5 days [26·0–66·0];
incident rate 2·0, 95% CI 1·8–2–2; p<0·0001), and mothers were notified of their infants’
test results faster (median 14·0 days [IQR 7·0–24·0] vs 23·0 days [13·0–33·0]; incident rate
1·6, 95% CI 1·3–2·0; p<0·0001), controlling for maternal age, education level, and HIV
disclosure status. Modified intention-to-treat analyses for these same outcomes retained
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significant interaction effects for PCR turnaround time (incident rate 2·0, 95% CI 1·8–2·2;
p<0·0001) and turnaround time for notifying mothers of results (1·5, 1·2–1·8; p=0·0002).
No difference was noted in mean infant age at 9-month and 18-month retesting between
intervention and control sites (mean age 9·4 months [SD 0·8] vs 9·4 months [1·2]; p=0·62;
and mean 18·7 months [1·5] vs 18·5 months [1·6]; p=0·13). Turnaround time for ART
initiation was longer at intervention hospitals compared with control sites (median 21·0 days
[IQR 4·0–66·0] vs 0·5 days [0·0–6·5]; p=0·;03).
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27 (84%) of 32 HIV-positive infants were diagnosed at their initial PCR test (20 of 21 at
intervention sites and seven of 11 at control sites), with three infants diagnosed at the 9month retest and two at the 18-month retest. One infant from a control site was diagnosed at
6 weeks but never started ART. Of the other 26 infants diagnosed HIV-positive at their first
test, age at ART initiation was younger at intervention sites compared with control sites (20
infants, median age 17·5 weeks [IQR 13·7–21·8] vs six infants, median age 25·1 weeks
[21·0–26·9]; p=0·04; figure 3). HIV-positive infants at control sites were older at the time of
sample collection for their first HIV test compared with those at intervention sites (median
age 11·4 weeks [IQR 8·7–15·4] vs median age 6·4 weeks [6·0–7·7]). Few infants who were
diagnosed after their first 6-week test initiated ART within the targeted first 12 weeks of life
(three [15%] of 20 at intervention sites and none at control sites). However, ten (50%) of 20
mothers of HIV-positive infants at intervention sites were notified of their infant’s result
before 12 weeks of age (median age at notification 12·5 weeks [IQR 10·6–15·4] vs 24·7
weeks [21·0–25·9] at control sites), making ART initiation before age 12 weeks feasible if
same-day or next-day ART initiation had been facilitated (PCR results were available at
median age 10·5 weeks [IQR 9·1–12·0] at intervention sites vs 17·7 weeks [13·1–23·6] at
control sites).
No adverse events were recorded that were related to participation in the HITSystem
intervention or this research study. During the study, 26 infant deaths were reported as
adverse events to the institutional review boards (17 at intervention sites and nine at control
sites), although none were related to study participation. In intention-to-treat analyses, more
deaths were reported among HIV-positive infants (three [8%] of 38) than among HIVnegative infants (23 [3%] of 770; p=0·09). The number of deaths among HIV-positive infants
at intervention sites (two [8%] of 25) was similar to the number at control sites (one [8%] of
13).

Discussion
Author Manuscript

The results of our cluster-randomised trial show significant improvements in early infant
diagnosis quality and efficiency achieved by the HITSystem intervention. Infants enrolled at
hospitals implementing the HITSystem were significantly more likely to receive complete
early infant diagnosis services. Hospitals of medium and lower patient volume using the
HITSystem had substantially increased odds of receiving complete early infant diagnosis
services, whereas no difference was noted between high-volume sites. In modified intentionto-treat analyses, in which all infant deaths and transfers were judged not to have completed
early infant diagnosis rather than regarded as exclusions, the intervention effect of the
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HITSystem on the primary outcome of complete early infant diagnosis remained significant.
Several significant efficiencies in early infant diagnosis services were achieved at sites
implementing the HITSystem; turnaround times for infant PCR test results were 2·6 weeks
faster than at control sites, and mothers were notified of their infants’ results 1·3 weeks
faster than at control sites. The turnaround time for infant PCR test results in our trial (20
days) was similar to that reported in an assessment of programmatic HITSystem
implementation (24·7 days).22 The turnaround time for ART initiation among infants
diagnosed HIV-positive, an important target for efficiency, was not improved at sites
implementing the HITSystem, and in fact was significantly slower. Despite these delays,
median infant age at ART initiation was 7·6 weeks younger at sites implementing the
HITSystem.

Author Manuscript
Author Manuscript

Updated 2014 policy guidance advised immediate ART initiation among HIV-positive
infants,23 but the speed of adoption varied across study sites. By the time our trial started, all
control sites had already adopted immediate ART initiation, which for many infants resulted
in ART initiation at the same visit when the mother was informed of the HIV-positive
results. Slower ART initiation at intervention sites was probably attributable to the practice
of requiring mothers to complete multiple adherence counselling sessions before ART
initiation, which was the norm at two of the three intervention hospitals. This practice
typically resulted in multiweek delays in initiating ART. We had not encountered this
practice of delayed ART initation in our pilot or programme sites and, thus, did not identify
this important disparity during initial site selection. During our trial, one of the two
intervention hospitals adapted their practice and began initiating ART after the first
adherence counselling session (typically 1–2 weeks after notification). Unfortunately, the
larger intervention facility, which contributed eight of 21 HIV-positive infants, did not
modify their practice during the study period. We do not believe that the HITSystem
accounted for this delay, because other Kenyan hospitals implementing the HITSystem
during an overlapping period reported shorter turnaround times between notification of the
mother and ART initiation (median 6·5 days).8 This practice revealed an important barrier to
rapid ART that requires greater emphasis at the county and health-facility level to ensure
updated treatment guidelines are implemented.

Author Manuscript

Most infants were diagnosed with HIV during their initial test. Although median infant age
at the first test was similar across implementation and control sites (6·3 weeks vs 6·4 weeks),
age at first test among HIV-positive infants at control sites was nearly twice that of HIVpositive infants at intervention sites (6·4 weeks vs 11·4 weeks). In view of the small sample
size of HIV-positive infants, this finding is difficult to explain and cannot be attributed
directly to the intervention, because engagement begins the day infants are brought to the
hospital for testing. Even with the improved efficiencies added by the HITSystem, delays in
ART initiation significantly reduced the proportion of infants initating ART within 12 weeks
of age, thereby reducing the maximum benefit of ART.5
Technology solutions for health-care and HIV services are quickly becoming part of the new
standard of care in Kenya, with 2016 national coverage of mobile phones estimated at 90%24
and the emergence of multiple electronic medical records systems to support HIV care at
government facilities. During the period of study implementation (2013–17), findings of
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four randomised controlled trials using text messaging outreach to mothers showed
significant improvements in PMTCT retention and uptake of early infant diagnosis services
(three in Kenya25–27 and one in Mozambique).28 In a 2016 systematic review,29 the effect of
mHealth interventions on improving PMTCT and early infant diagnosis was summarised
from five studies, with a significant increase reported in early infant diagnosis uptake at 6
weeks post partum (pooled relative risk 1·2, 95% CI 1·1–1·3). Findings of a 2017 systematic
review30 ascertained that SMS and general packet radio service (GPRS) printers reduced
turnaround time for infant PCR test results by 25% compared with a paper-based courier
(51·1 days vs 68·0 days). Our trial provides the most comprehensive evidence to date of the
success of an mHealth intervention to improve quality and efficiency across the complete
early infant diagnosis cascade of care.

Author Manuscript
Author Manuscript

Strengths of our trial include its prospective design and the long duration of infant follow-up
(until 18 months post partum). In most studies reporting uptake of early infant diagnosis
services, infants have been followed up until the result of their first infant PCR test (typically
8–10 weeks post partum). Few studies report ART initiation for infants diagnosed with HIV
and, to our knowledge, no other Kenyan studies assessing early infant diagnosis have
reported infant age at ART initiation. The aggregate measure of complete early infant
diagnosis services provides a new and more comprehensive outcome to measure the quality
of early infant diagnosis services across the full cascade of care for both HIV-positive and
HIV-negative infants. Multiple standalone measures of early infant diagnosis efficiency are
reported by us here, including turnaround time for notifying the mother of PCR results and
infants’ ages at targeted retesting timepoints, which are rarely reported in studies. In Kenya,
considerable investments in PMTCT and early infant diagnosis services have occurred over
the study period. Establishing intervention efficacy against a continually improving standard
of care presents a challenge for studies with multiyear follow-up periods. Nevertheless,
significant intervention effects were achieved in our trial, even with modified intention-totreat analyses.

Author Manuscript

Limitations of our trial include the small number of clusters and the imbalance in number of
patients at the high-volume cluster. Randomisation at the level of clusters (hospital) reduces
comparability between mother–infant pairs (unit of analysis) compared with randomisation
at the individual level. Significant differences in maternal characteristics existed between
implementation and control sites, with mothers at control sites (receiving the standard of
care) reporting greater education and higher rates of HIV disclosure compared with those at
implementation sites (enrolled in the HITSystem); both of these variables are associated
with better adherence to PMTCT and early infant diagnosis guidelines.6,31,32 Older maternal
age is also associated with better adherence to PMTCT and early infant diagnosis services,31
and although mothers at implementation sites were older than those at control sites, the
difference of just over 1 year (mean age 30·2 years vs 29·0 years) is not meaningful. We
included only mother–infant pairs who presented for early infant diagnosis through the
maternal and child health department of the hospital before age 24 weeks. The intervention
might vary in efficacy for those engaging in early infant diagnosis at a later age or who are
identified through different hospital departments, reflecting a population who might be less
engaged in care. Although mothers younger than 18 years (roughly 2% of all mothers
enrolled in the HITSystem during the active study enrolment period) were excluded from
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analyses, inclusion criteria for future research will include younger mothers who might face
more barriers to retention. The use of clinical staff at control sites to enrol participants,
compared with a dedicated research staff at intervention sites, could account for missed
enrolment opportunities, in view of multiple demands on clinical providers. Higher numbers
of transfers were recorded at intervention facilities than at control sites, which probably
reflects the improved documentation of data with the HITSystem compared with the
standard-of-care paper-based registries. Poorer quality and incompleteness of clinical
records and infant registries at control sites could have biased outcomes. However, rigorous
and repeated efforts to cross-reference multiple sources of data helped to optimise the
quality and accuracy of control data.
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The HITSystem is an innovative public health intervention that makes the most of accessible
mobile and internet technology to significantly improve the quality and efficiency of early
infant diagnosis services in Kenya and other low-resource settings. Qualitative data from
interviews with mothers at intervention and control sites emphasise the same themes of early
infant diagnosis quality and improved efficiency gained with the HITSystem.33 Usersatisfaction data from clinical and laboratory providers have described the ease of use and
perceived usefulness of the HITSystem,34 which contributes to successful adoption of the
system in programmatic settings. The HITSystem has been reconfigured to support Kenya’s
new and more intensive algorithm for early infant diagnosis testing. As point-of-care infant
HIV testing expands and eliminates the need for sample tracking features, the participanttracking features of the HITSystem maintain relevance to ensure infant retesting and
retention throughout the early infant diagnosis cascade. A cost-effectiveness analysis
currently underway will inform decisions about national and potentially regional scale-up of
the HITSystem. Wider use of a system-level intervention that accelerates diagnosis and
supports retention among mother–infant pairs can be implemented to significantly
strengthen HIV prevention and treatment for improved maternal and paediatric health
outcomes.
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Research in context
Evidence before this study

Author Manuscript

We searched PubMed, the Cochrane Library, and Google Scholar between Jan 1, 2008,
and Dec 31, 2012, with the terms “early infant diagnosis”, “early infant diagnosis
retention”, “infant ART initiation”, “HIV-exposed infants”, “turn-around time for infant
HIV DNA PCR results”, “mHealth”, “eHealth”, “mobile phones”, “Internet”, and “early
infant diagnosis cascade of care”. When we had the idea for the study in 2012, no
published data were available from randomised controlled trials assessing paediatric HIV
or early infant diagnosis outcomes with mobile phone or internet components. During the
course of this study (2013–18), evidence has accumulated supporting the usefulness of
mobile health (mHealth) interventions—including short message service (SMS) text
messaging—to improve early infant diagnosis uptake, completion of the initial test, and
turnaround time for PCR results.
Added value of this study

Author Manuscript

To the best of our knowledge, we have done the first cluster-randomised trial of an
intervention using a combination of SMS and internet technology to target both clinical
and laboratory outcomes across the complete 18-month early infant diagnosis cascade.
The HITSystem is a novel integrated system linking multiple stakeholders, including
early infant diagnosis providers, laboratory technicians, and mothers and infants. The
primary outcome was an aggregate measure of complete early infant diagnosis, which is
a new approach to measuring the quality of early infant diagnosis that reflects receipt of
all indicated services along the cascade of care. Eligibility of participants for each early
infant diagnosis intervention was assessed according to previous HIV test results,
allowing quality and efficiency of services to be measured contextually at each stage. To
increase the generalisability of findings, hospitals were stratified by volume of patients
(high, medium, and low) to assess implementation experiences in multiple settings.
Implications of all the available evidence

Author Manuscript

Our study provides the most comprehensive evidence to date of the feasibility and utility
of an mHealth early infant diagnosis intervention to significantly improve the quality
(complete early infant diagnosis services) and efficiency (turnaround time for PCR
results and notifying the mother of the PCR results) of early infant diagnosis services.
Even in remote settings, internet-based interventions accessed by modems at hospitals
and central laboratories—such as the one evaluated here—have proved feasible, and text
messaging is now ubiquitous in Kenya.
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For the study protocol see https://globalhealthinnovations.org/research
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Figure 1: Trial profile
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Participants enrolled after Dec 31, 2015, were excluded from this analysis to permit
complete follow-up until age 18 months for all participants. Missed opportunities for
enrolment included mother–infant pairs enrolled in early infant diagnosis who were not
assessed for study eligibility and recruitment.Three of 65 documented transfers or moves at
the intervention site were mothers who refused treatment (one refused ART, two refused to
undergo early infant diagnosis) and, thus, were not deemed candidates for ART.
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Figure 2: Proportions of participants receiving complete early infant diagnosis services

Proportions were adjusted for significant covariates, comprising maternal age, maternal
education level, HIV disclosure status, hospital volume, and arm × volume interaction.
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Figure 3: Turnaround times for each step of early infant diagnosis in infants diagnosed with HIV
at their initial PCR test
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At control sites in infants diagnosed HIV-positive at their first test (n=6), a dried bloodspot
was obtained at median age 11·4 weeks (IQR 8·7–15·4), the PCR result was available after a
further 6·3 weeks, the mother was notified of this result after 7·0 weeks, and ART was
initiated after another 0·4 weeks. At intervention sites in infants diagnosed HIV-positive at
their first test (n=20), a dried bloodspot was obtained at median age 6·4 weeks (IQR 6·0–
7·7), the PCR result was available after a further 4·1 weeks, the mother was notified of the
result after 2·0 weeks, and ART was initiated after another 5·0 weeks. ART=antiretroviral
therapy.
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Participants’ baseline characteristics
Intervention (n=392)

Control (n=298)

High volume

226 (58%)

115 (39%)

Medium volume

109 (28%)

99 (33%)

Low volume

57 (15%)

84 (28%)

Study sites

Maternal age (years)

30·2 (6·0)

29·0 (5·4)

Median (IQR)

29·0 (26·0–35·0)

29·0 (25·0–32·0)

35 (9%)

7 (2%)

Partial education up to completion of primary education

199 (51%)

155 (52%)

Partial secondary education and beyond

151 (39%)

129 (43%)

7

7

Yes, live together

274 (70%)

211 (71%)

No current partner

110 (28%)

70 (23%)

Education level
No formal education
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Missing data
Partner status

Missing data

8

17

252 (64%)

212 (71%)

<750 KSH

211 (54%)

162 (54%)

≥750 KSH

153 (39%)

116 (39%)

28

20

159·1 (107·9)

141·15 (151·8)

8

10

Male

193 (49%)

151 (51%)

Female

199 (51%)

145 (49%)

Disclosure of HIV status to anyone
Income level*

Missing data
Travel costs to hospital (KSH)*
Missing data
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Infant sex

Missing data
Infant age at first PCR (weeks)
Missing data

0

2

6·3 (6·0–6·7)

6·4 (6·1–7·4)

0

1

Data are n (%), mean (SD), or median (IQR).

*

100 KSH is roughly US$1.
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46/57 (81%, 71–91)

Low volume (n=141)

†
334/474 (70%, 66–75)

180/334 (54%, 49–59)

180/298 (60%, 55–66)

26/84 (31%, 21–41)

55/99 (56%, 46–66)

99/115 (86%, 80–93)

Control (n=298)

2·0 (1·6–2·8)

3·7 (2·5–5·5)

9·4 (4·2–21·4)

16·8 (6·3–44·9)

0·7 (0·4–1·3)

Adjusted odds ratio (95% CI)*

Infant deaths and transfers regarded as incomplete early infant diagnosis.

†

Adjusted for maternal age, education level, and HIV disclosure status.

*

0·28

<0·0001

<0·0001

<0·0001

<0·0001

Data are n (%, 95% CI). Table shows the differential effect of the HITSystem by hospital volume and analysis strategy.

Intention to treat

Standard

334/392 (85%, 82–89)

104/109 (95%, 92–99)

Medium volume (n=208)

Analysis strategy

184/226 (81%, 76–87)

High volume (n=341)

Hospital volume

Intervention (n=392)

p value
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Sensitivity analyses for the primary outcome of complete early infant diagnosis
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